TRCT
Tower Research Capital (TRC)’s VanEck Pharmaceutical ETF PPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05M | Buy |
34,624
+34,614
| +346,140% | +$3.04M | 0.08% | 224 |
|
|
2025
Q1 | $911 | Sell |
10
-34,541
| -100% | -$3.15M | ﹤0.01% | 4804 |
|
|
2024
Q4 | $2.98M | Buy |
34,551
+5,313
| +18% | +$458K | 0.06% | 259 |
|
|
2024
Q3 | $2.78M | Buy |
+29,238
| New | +$2.78M | 0.07% | 191 |
|
|
2024
Q2 | – | Sell |
-3,585
| Closed | -$325K | – | 5937 |
|
|
2024
Q1 | $325K | Sell |
3,585
-19,141
| -84% | -$1.74M | 0.01% | 1111 |
|
|
2023
Q4 | $1.85M | Buy |
22,726
+6,232
| +38% | +$507K | 0.02% | 539 |
|
|
2023
Q3 | $1.32M | Buy |
16,494
+8,975
| +119% | +$717K | 0.04% | 435 |
|
|
2023
Q2 | $592K | Sell |
7,519
-22,048
| -75% | -$1.74M | 0.02% | 859 |
|
|
2023
Q1 | $2.3M | Buy |
+29,567
| New | +$2.3M | 0.07% | 170 |
|
|
2022
Q4 | – | Sell |
-51,808
| Closed | -$3.48M | – | 6254 |
|
|
2022
Q3 | $3.48M | Buy |
51,808
+46,978
| +973% | +$3.16M | 0.06% | 270 |
|
|
2022
Q2 | $371K | Buy |
+4,830
| New | +$371K | 0.01% | 1326 |
|
|
2022
Q1 | – | Sell |
-7,641
| Closed | -$588K | – | 6455 |
|
|
2021
Q4 | $588K | Sell |
7,641
-10,162
| -57% | -$782K | 0.01% | 1004 |
|
|
2021
Q3 | $1.3M | Sell |
17,803
-11,877
| -40% | -$865K | 0.03% | 406 |
|
|
2021
Q2 | $2.17M | Buy |
29,680
+16,562
| +126% | +$1.21M | 0.06% | 279 |
|
|
2021
Q1 | $905K | Buy |
13,118
+12,145
| +1,248% | +$838K | 0.02% | 831 |
|
|
2020
Q4 | $65K | Buy |
973
+466
| +92% | +$31.1K | ﹤0.01% | 2825 |
|
|
2020
Q3 | $32K | Sell |
507
-12,783
| -96% | -$807K | ﹤0.01% | 3705 |
|
|
2020
Q2 | $827K | Buy |
+13,290
| New | +$827K | 0.03% | 648 |
|
|
2020
Q1 | – | Sell |
-13,927
| Closed | -$893K | – | 3704 |
|
|
2019
Q4 | $893K | Buy |
13,927
+12,365
| +792% | +$793K | 0.07% | 137 |
|
|
2019
Q3 | $89K | Sell |
1,562
-40,426
| -96% | -$2.3M | 0.01% | 1426 |
|
|
2019
Q2 | $2.46M | Buy |
41,988
+30,642
| +270% | +$1.8M | 0.17% | 84 |
|
|
2019
Q1 | $689K | Buy |
11,346
+5,768
| +103% | +$350K | 0.04% | 427 |
|
|
2018
Q4 | $305K | Buy |
5,578
+1,644
| +42% | +$89.9K | 0.02% | 565 |
|
|
2018
Q3 | $253K | Sell |
3,934
-23,306
| -86% | -$1.5M | 0.02% | 842 |
|
|
2018
Q2 | $1.61M | Buy |
27,240
+8,860
| +48% | +$523K | 0.09% | 208 |
|
|
2018
Q1 | $1.05M | Sell |
18,380
-12,106
| -40% | -$688K | 0.09% | 184 |
|
|
2017
Q4 | $1.81M | Buy |
30,486
+30,014
| +6,359% | +$1.78M | 0.23% | 87 |
|
|
2017
Q3 | $27K | Sell |
472
-16,116
| -97% | -$922K | ﹤0.01% | 2527 |
|
|
2017
Q2 | $980K | Buy |
16,588
+16,290
| +5,466% | +$962K | 0.11% | 140 |
|
|
2017
Q1 | $16K | Buy |
298
+131
| +78% | +$7.03K | ﹤0.01% | 1438 |
|
|
2016
Q4 | $9K | Sell |
167
-275
| -62% | -$14.8K | ﹤0.01% | 2724 |
|
|
2016
Q3 | $25K | Buy |
+442
| New | +$25K | ﹤0.01% | 1490 |
|